[Clinical aspects of the problem of treating leukemias].
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D002713:Chlorine; D002908:Chronic Disease; D003630:Daunorubicin / Q000627:therapeutic use; D004117:Dimethoate / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005021:Ethylamines / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007165:Immunosuppression Therapy; D007938:Leukemia / Q000188:drug therapy / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D007958:Leukocyte Count; D008218:Lymphocytosis / Q000628:therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D012075:Remission, Spontaneous
D000970:Antineoplastic Agents; D005021:Ethylamines; D005938:Glucocorticoids; D007136:Immunoglobulins; D002699:Chlorambucil; D002713:Chlorine; D011239:Prednisolone; D015122:Mercaptopurine; D004117:Dimethoate; D008727:Methotrexate; D003630:Daunorubicin
Klinicheskie aspekty problemy lecheniia leĭkozov.